Hainan Haiyao (000566.SZ): The recent short-term increase in stock price poses a risk of the market being overheated.

Hainan Haiyao (000566.SZ) issued a price abnormality and risk warning announcement, stating that the company's price-to-book ratio deviates from the average level of the "pharmaceutical manufacturing industry." According to data from the website of China Securities Index Co., Ltd., as of September 13, 2024, the company's price-to-book ratio is 3.78; the price-to-book ratio of the "pharmaceutical manufacturing industry" to which the company belongs is 2.25. The company's current price-to-book ratio is higher than the aforementioned "pharmaceutical manufacturing industry" price-to-book ratio. Recently, the company's stock price has experienced a large short-term increase, deviating significantly from the market trend, posing a risk of market sentiment being overheated. However, there have been no significant changes in the company's fundamentals, and there is no undisclosed material information that should be disclosed.